Major television campaign launched for CBD in the UK
BRITISH CANNABIS™ has successfully launched a major media campaign for CBD in the UK, a significant milestone for spreading awareness and changing perceptions about...
Chronic spontaneous urticaria: could the answer be in CBD?
Dr Sari Prutchi Sagiv, CSO of Stero Biotechs, explains why CBD could be a potential treatment for chronic spontaneous urticaria.
Urticaria can be caused by...
Symtomax: innovation in European cannabis
Portugal-based cannabis producer Symtomax deploys industry experience and genetic expertise to deliver high-quality, market-leading products.
Symtomax has been granted approval by INFARMED, the Portuguese regulatory...
UK prescription cannabis recalled that ‘may be contaminated with mould’
UK prescription cannabis supplier NOIDECS has recalled two batches of product and has advised patients not to use their prescription medicine after reports of...
Exploring the emerging UK CBD industry
In this article, Rick Brar, CEO of Brains Bioceutical, explores the emerging UK CBD industry.
The last two years have seen the UK CBD market...
GCI Summit: exploring cannabis and psychedelics
This week, the GCI Summit gives global leaders the opportunity to network with the best minds in cannabis and psychedelics.
Taking place from 8 to...
Natural versus synthetic CBD
Richard O’Halloran, CEO of Biosportart, discusses natural versus synthetic cannabidiol (CBD) compounds for use in products and what this means for the CBD industry.
CBD...
XPhyto: Is mescaline the next big mood-modifying medicine?
Mescaline has the potential to be the next frontier in the psychedelics renaissance and represents an unprecedented opportunity to innovate a notable advancement in...
Greenheart CBD: the first company to introduce a CBD DeFi token
Greenheart offers premium seed-to-shelf CBD and an innovative decentralised finance token.
Greenheart CBD is an Irish-owned company with a vision to bring the finest Irish-made...
Cannalean cannabis edibles for reducing cholesterol
Cannalean’s unique CBD formulation could help to treat dyslipidaemia, without the side effects of statins.
My 52-year-old husband is usually very healthy. He exercises daily,...
Medical cannabis ‘made in Denmark’
How Aurora Europe is ensuring reliable access to high-quality medical cannabis for Europe and beyond.
There is growing recognition in Europe and across the world...
Medical cannabis for endometriosis pain management
During Endometriosis Awareness Month, Sapphire Medical Clinics discusses how medical cannabis can help manage the chronic pain associated with the condition.
Endometriosis is often associated...
The future of CBD wellness products
The future is looking promising for businesses hoping to tap into the growing CBD and wellness space.
The global market for cannabidiol (CBD), valued at...
Australian biotech company leads the way medical cannabis
CannaPacific is building a solid foundation to become a major player in the global medical cannabis sector.
A little-known Australian biotech company, CannaPacific, is building...
Khiron extends medical cannabis expertise from Latin America to Europe
Khiron extends expertise towards the growing EU medical cannabis market.
Khiron Life Sciences is a patient-focused, global health and wellness company capitalising on the fast-growing...
Cannabis investment, regulation, and opportunity in Latin America
How a Canadian company is meeting the demand for pharmaceutical cannabis products in Latin America.
The primary goal of Canadian supplier VerdeMed is to deliver...
Project Twenty21 receives new medical cannabis range
Project Twenty21 and LYPHE Group have created a partnership for a new range of medical cannabis products for the registry.
The partnership will see LYPHE...
New UK medical cannabis products cheaper and safer than black market
Sapphire Medical Clinics are first to offer access to a new range of UK manufactured medical cannabis products which are now cheaper and safer...
Medical cannabis: science and risk-based methodology
Independent consultancy NNE and venture advisory firm Volvér showcase the significance of science and risk in devising a manufacturing facility.
How can cannabis producers bring...
LeafCann secures cannabis import licence from Australian Government
Privately-owned medicinal cannabis company LeafCann has secured a Medicinal Cannabis import licence from the Australian Government.
The licence, which will enable LeafCann to supply Australian...
